Connect with us

Pandemic

NEW: COVID-19 cases drop under 500 in Nevada, and below 300 in Clark County

Published

on

See the full COVID-19 report for October 14th below.

LAS VEGAS (KLAS) – Clark County’s new COVID-19 cases have dropped below 300 for the first time since June, according to data released today. Nationwide, the cases fell to below 500 by the weekend.

The drop in daily cases is the latest good news as the summer spike in COVID-19 cases eases.

The state reported 10 deaths, five of which were from Clark County.

The test positive rates for the state and county were unchanged since yesterday. Nevada’s rate is 7.9% and the county’s rate is 6.9%. Nine of the state’s 17 counties still have rates of 10% or more, with Elko County beating the rest at 22.6%.

Cases shifted away from Clark County in the last month of the current COVID-19 spike, but the mask mandate has remained nationwide. The state follows the guidelines of the Centers for Disease Control and Prevention on the mask rule. The mandate remains in force in each county until the following conditions are met:

  • The COVID-19 test positivity rate must be less than 8%
  • The fall rate (per 100,000 inhabitants over 7 days) must be below 50.

Clark County is currently 6.9% test positive and the fall rate is 105.5, according to the Southern Nevada Health District.

Nevada continues to be identified as a place of high transmission of COVID-19 and Clark County remains “an area of ​​concern,” according to an updated White House report. The district was first referred to as a “sustainable hotspot” on July 5th.

Almost all of Nevada is designated as a “High Transmission” area. The CDC uses cases per 100,000 in the past seven days to determine high transmission.

A BREAKDOWN OF CASES, DEATHS AND TESTS

The number of cases in Nevada rose 495 last day, to 255 in Clark County last day. The total number of cases in the state now stands at 430,665. Clark County has a total of 326,538. It’s important to note that the state no longer updates the dashboard on weekends or holidays, so reports may have higher case and death rates on Monday and Tuesday.

You can find this data under the “Current Status – Confirmed Cases” tab of the DHHS dashboard

Nevada’s test positive rate is 7.9%, unchanged from yesterday. It fell below 5.0%, the World Health Organization target, on May 17, and rose above it on June 28. Clark County’s rate is 6.9%, unchanged from yesterday.

Of the 10 other deaths related to COVID-19, five were from Clark County. Southern Nevada now accounts for 5,835 of the state’s 7,422 deaths. The 14-day moving average is 12 deaths per day.

As of September 30, the Southern Nevada Health District reports 158 groundbreaking deaths, 482 groundbreaking hospital admissions, and 10,449 groundbreaking cases. The county did not give an update last week.

As of yesterday, Nevada had a total of 5,086,134 COVID-19 tests, up from 12,825 since yesterday.

* NOTE: Daily laboratory data from DHHS and SNHD reports are provided every morning for the Previous day.

TRACKING NV COUNTIES

Clark County’s test positive rate has dropped below 8%, removing the county from the state watch list due to increased risk of transmission. If the county can maintain test-positive and testing levels, state restrictions – including mask requirements – could be relaxed. A separate measure of the county’s case rate – currently 105.5 cases per 100,000 residents in the last seven days – must drop below 50 for two weeks before the mask mandate can end.

In today’s report, Churchill, Douglas, Elko, Humboldt, Lander, Lyon, Mineral, Nye, Storey, and Washoe Counties are featured.

The Clark County’s fall rate (508 per 100,000 in the last 30 days) is flagged in the data reported today. Test positive rate (6.9%) and tests (354 tests per day per 100,000) are in the acceptable range for the state.

VACCINATION UPDATE

The country’s health department reports 3,196,188 cans of the COVID-19 vaccine were administered in Nevada, from October 14th.

To date, 55% of Nevadans currently eligible for the vaccine are fully vaccinated, and more than 63% of the eligible population have started vaccinations. Clark County reports that 54% of eligible residents are fully vaccinated.

A DISTRIBUTION OF HOSPITALS IN NEVADA

NOTE: The state does not update hospitalization information Weekends or holidays.

According to the state’s Department of Health (DHHS), the number of hospitalized patients was in Nevada HIGH (+1) on the last day.

The current number of hospital admissions is 749 confirmed / suspected cases. Hospitals reported that 151 of these patients were in intensive care units and 104 on ventilators. To give some perspective, the state set a record high for hospital patients on December 13 with 2,025 cases.

The Nevada Hospital Association did not submit a weekly COVID update last week. It was expected to return on October 13, but no update has been provided.

You can find this data under the “Current Status – Hospital Stays” tab of the DHHS dashboard

RECOVERY FALLS IN SOUTHERN NEVADA

The number of people in southern Nevada who have recovered from the virus continues to rise. The latest county update estimates a total of 310,921 recovered cases; that’s 95.2% of all reported cases in the county, according to the latest report from SNHD.

The health district provides a daily map showing the number of positive tests in each Clark County zip code.

MITIGATION MEASURES IN NEVADA

Nevada was born on Jan.

The CDC reversed course on July 27, saying that fully vaccinated Americans in areas of “significant and high” public transmission should wear masks if COVID-19 cases increase. Most of Nevada falls into these two risk categories.

Nevada said it will adopt the CDC’s guidelines with the new mask guideline, which went into effect on July 30 at 12:01 am. This overrides the Clark County’s employee mask mandate that came into effect in mid-July.

On August 16, Governor Sisolak signed a new policy allowing fully vaccinated attendees to remove their masks at large gatherings, but only if the venue decides that everyone present must provide proof of vaccination. Those who only have one vaccination and are not “fully vaccinated” would still be able to participate, as would children under the age of 12, but both would have to wear masks.

Masks must continue to be worn if required by state, state, local, tribal, or territorial laws, rules and regulations, including local business and workplace guidelines.

SEE ALSO: Report from the previous day

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Pandemic

Anchorage’s busiest COVID-19 testing site, at Loussac Library, closes with no notice as city switches contractor

Published

on

Anchorage’s busiest COVID-19 testing site at the Loussac Library was abruptly closed Wednesday and replaced in a new location operated by a different company on a nearby vacant lot belonging to the Anchorage Neighborhood Health Center.

The sudden shutdown came as city health officials announced changes in the way the community is handling COVID-19 testing.

Long-time test entrepreneur Visit Healthcare is being replaced by Capstone Family Medicine, a Wasilla-based company that operates medical clinics but also operates numerous COVID-19 test sites across the state, including at airports and in local communities.

“Capstone is now in charge of the testing as it is the more efficient and cost-effective option,” Anchorage Department of Health spokesman Robert McNeily said in an email on Wednesday afternoon.

The tests remain free, city officials said.

“The tests are not going away,” said Joe Gerace, director of the Anchorage Department of Health, during a meeting on Wednesday, pointing out that the city is adding a testing site in West Anchorage. “… there are no costs yet.”

A primary reason for the move is that Capstone can charge health insurance for testing, which Visit Healthcare doesn’t, according to Anchorage Congregation member Kameron Perez-Verdia, co-chair of the Health Policy Committee, who spoke with Gerace after the To meet.

“Visit isn’t really geared towards doing the same type of billing as Capstone, and that’s the main problem,” said Perez-Verdia. “You want to switch to an organization that can bill insurance companies.”

People without insurance will continue to be offered free tests, he said.

“They are still being tested, but now they also have the option to charge this,” said Perez-Verdia.

A spokesman for the mayor’s office confirmed that free tests are still available and that the city has switched providers to settle the insurance.

Visit Healthcare learned Tuesday that the Loussac site will be closing the next day, according to Chris Koone, the company’s operations manager. Local officials told him traffic problems and lack of funding went into the decision, Koone said.

The Loussac site, which ran 5,600 tests last month, is more than twice as busy as any other urban test site, he said.

It wasn’t immediately clear why the transition was so abrupt.

According to McNeily, Capstone now “technically” operates seven test locations in the city. The company already operates state test sites at Ted Stevens Anchorage International Airport and the University of Alaska Anchorage.

Four sites currently operated by Visit Healthcare will be “phased out” for five Capstone sites, he said: an Eagle River site that was converted last week; the new Loussac replacement in 4810 C St .; a popular website for the Changepoint Church; a test site in the Muldoon area; and a new location in Alaska Park near the airport.

The sites will be in the hands of Capstone by mid-December, McNeily said.

A Capstone representative didn’t respond to questions on Wednesday.

The test change was announced on the same day that the Omicron variant of the coronavirus was first discovered in the United States. There’s no sign of Omicron arriving in Alaska, where the number of daily new cases and hospital admissions are declining after rising so much in the fall that the state released crisis standards for care in early October to ease the pressure to reduce overwhelmed hospitals.

[Impossible choices inside Alaska’s inundated hospitals]

Now two out of three hospitals in Anchorage – Providence Alaska Medical Center and Alaska Regional Hospital – are out of crisis mode.

In an interview on Wednesday, McNeily, spokesman for the city’s health department, said the community might consider reducing test levels if COVID-19 transmission rates continue to drop. The virus is now reproducing below one, meaning less than one person is infected at a time.

That trend could change, he continued, “but the rate has continued to fall in recent weeks. AHD continues to be cautiously optimistic about the future, as the local hospitals are outside the standards of crisis care. “

In general, health professionals say wide access to testing is important regardless of hospital admissions, which are delayed markers of the presence of the virus. Tests track the spread of the virus – particularly with the possibility of a new variant floating around – but also prompt early treatment, which will help slow new cases that could eventually lead to hospitalizations.

In addition to the urban locations, free trials are also available at the Walgreens Pharmacy locations in Anchorage.

Tests for people without symptoms are also possible at Ted Stevens Anchorage International Airport, although this location was moved behind security as of Wednesday, only for passengers with tickets and staff with ID.

Gerace also announced on Wednesday that the municipality is moving from an urban funding model to a federal model.

Local officials say they want to contain the cost of the testing program. At Visit Healthcare, each test costs about $ 100. The tests are reimbursed by the Federal Emergency Management Agency, but the city will have to pay for up to a year, Gerace said.

The city cited brief funding in October as a reason to cut free testing during the summer and fall of the COVID-19 surge. The convention later approved a $ 2.65 million motion from the Bronson administration that fully restored test levels by November.

Meg Zaletel, member of the Anchorage Congregation, vice chair of the health policy committee, said the health department’s announcement came as a surprise and she is still trying to get more information.

“I don’t know much yet. The (health) description was not very informative, ”said Zaletel on Wednesday morning. “They had a preview to find a more cost-effective model for treatment. I don’t know what they switched to, but the fact that they made a change to try to cut costs is not surprising. “

It wasn’t immediately clear why the city switched testing in Midtown from the well-known, popular Loussac Library website to an empty lot on C Street.

Corey Allen Young, mayor’s spokesman, said the decision to move the site between Capstone and the city was made for “better access.”

“There is a kind of traffic jam at Loussac. I’ve seen it every time I’ve come to congregation meetings, ”said Young. The new location next to the Anchorage Neighborhood Health Center “just offers a little more space,” he said.

Young did not comment on why the website was moved without widespread public announcement, and referred the Daily News to the health department.

The change to a new location and provider was “really disruptive,” said Perez-Verdia.

“That’s one of the problems … from your point of view, this could be more efficient. And certainly being able to bill (insurance) is good in my opinion, ”he said. “But we have to be able to communicate this really well so that people know what’s going on and why.”

At least one Anchorage resident took to Twitter Wednesday to share their issues with the test transition.

Q / 🧵: Why did #ANCgov change the Covid testing system that worked well?

I got double vaccinated and got what felt like a cold – I need a Covid test to diagnose whether or not this is a breakthrough case so I can avoid exposing others.

– Jenny-Marie Stryker (@StrykerJenny) December 1, 2021

Jenny-Marie Stryker, who is fully vaccinated against COVID-19, decided to get tested after noticing a stuffy nose and headache. Stryker checked the city testing website and found that the Loussac was closed for testing. She drove to the University of Alaska test site in Anchorage, which was also closed.

At the construction site on C Street, it took 5 or 10 minutes for anyone to get out, just to tell her that a defective generator was delaying testing. The Stryker was eventually tested, even though it took nearly an hour.

“Long enough to write this Twitter thread,” she said.

Continue Reading

Pandemic

How quickly does protection wane after the Pfizer COVID-19 vaccine?

Published

on

Share on PinterestA new study examines the waning protection of the Pfizer vaccine over 180 days. picture Alliance / Getty Images

  • The researchers looked at whether COVID-19 immunity decreased after receiving a second Pfizer BioNTech mRNA vaccine dose.
  • They found that the likelihood of SARS-CoV-2 infection increases the more time passes after the second dose of vaccine.
  • While their results may justify booster vaccines for immunocompromised individuals, they warn that further research is needed as they did not use blood tests to monitor participants’ immune responses over time.

Protection against COVID-19 consists either in contracting the SARS-CoV-2 virus and recovering or getting vaccinated.

Research has shown that those who have become infected with SARS-CoV-2 are 85% protected from symptomatic illness 6 months after infection.

As the authors of the most recent study explain, “vaccinations at different points in time have been reported to be 50–95% effective”.

Over time, the immune system’s response to SARS-CoV-2 decreases, which means those who have recovered from the virus or received a vaccination may be less protected over time.

In a recent study, researchers from Israel and the United States conducted a study to investigate whether infection protection deteriorated over time after a second dose of the Pfizer BioNTech mRNA vaccine.

They found that people were at increased risk of contracting SARS-CoV-2 90 days after a second dose of Pfizer. The results appear in the BMJ.

“Israel was one of the first countries to successfully run a popular vaccination campaign, so we were among the first to see the vaccine waning over time since the first two vaccinations,” said Dr. Ariel Israel, Ph.D., one of the study’s authors, told Medical News Today.

“Our study is an observational study designed to determine whether the protection provided by the Pfizer vaccine wears off over time by comparing the positive rate [reverse transcription-polymerase chain reaction (RT-PCR) for SARS-CoV-2] in people who were vaccinated at different intervals before the test. “

“We have observed that after the excellent protection that the vaccine provides for the first 3 months, the rate of infection gradually increases,” said Dr. Israel.

The researchers collected medical records from Leumit Health Services, a major healthcare provider in Israel that serves 700,000 people across the country.

For their analysis, they used health records from people aged 18 and over who had a SARS-CoV-2 RT-PCR test between May 15, 2021 and September 17, 2021 after receiving two doses of the Pfizer vaccine had.

The team ran tests at least 3 weeks after the second vaccination. They divided participants into three age groups to reflect the different stages of vaccine introduction:

  • 60 years and older
  • 40–59 years
  • 18–39 years

They also divided the time between the second vaccination and the RT-PCR tests after the first 90 days into 30-day intervals, with the latter category being labeled 180 days or more since the second vaccination. In total, the researchers analyzed health records from 83,057 people.

Their analyzes took into account potentially confusing risk factors for SARS-CoV-2 infection such as age, gender, socio-economic status, and existing health conditions.

Of the researchers examined, 9.6% or 7,973 people had a positive test result. The mean time between the second dose of vaccine and an RT-PCR test was 164 days.

The team found that the likelihood of contracting SARS-CoV-2 increases the more time has passed since the second vaccine.

While 1.3% of the participants received a positive test result 21–89 days after the second vaccination, this was in 2.4% of the persons after 90–119 days and 4.6% after 120. the case149 days, 10.3% after 150179 days and 15.5% after 180 days.

These results resulted in a 2.37-fold higher chance of contracting the virus 90 days after the second vaccination and a 2.82-fold higher chance of 150 days or more.

They also found that two injections 21 days apart provided more protection than one and that age-related changes in the immune system affected the immune response to the vaccines.

Dr. Israel stated that the reasons for the deteriorating immune protection “are outside the scope of their study”. However, he suggested a few possible mechanisms:

“The most likely explanation is that antibodies, as well as cells of the immune system that produce antibodies or kill cells” [with the infection], have a finite lifespan, so their numbers gradually decrease after the first reaction caused by the vaccine.

“[Fewer] Antibodies in the blood and [fewer] Cells that can kill the virus mean that the virus is more likely to escape the immune system in the early stages of infection, so we are likely seeing an increased rate of positive PCR in people who have been vaccinated earlier, ”he added.

The researchers concluded that SARS-CoV-2 immunity wears off after a second Pfizer vaccine after the first 90 days and that a third vaccine or booster dose for immunocompromised individuals might be warranted.

They also note some limitations to their study. Because of the observational study design, they state that they may not have considered all of the contributing factors, which could have skewed their results.

For example, they find that they only included people who had chosen to request an RT-PCR test for SARS-CoV-2, and that some may have different thresholds for requesting a test.

They also found that people who were vaccinated earlier may have had different physical distancing habits than those who were vaccinated later, which could have significantly affected their level of risk.

In addition, the researchers note that blood tests were not done on RT-PCR tests, which means they cannot be sure whether the immunity had actually decreased.

“Given these results, Israel’s public health authorities have recommended booster vaccinations for all ages, and we saw a dramatic decrease in COVID-19 incidence immediately after the booster was introduced,” said Dr. Israel.

“It is too early to be able to say for sure how long the protection would last after the booster shot. We will continue to monitor the infection rate and will report our data if we see any reduction in protection from the booster, ”he concluded.

For live updates on the latest developments regarding the novel coronavirus and COVID-19, click here.

Continue Reading

Pandemic

Indiana’s secret weapon in the fight against COVID-19

Published

on

INDIANAPOLIS (WANE) – The Regenstrief Institute may be better known around the world than it is in its home state of Indiana, despite playing a key role in fighting COVID-19.

In fact, Regenstrief’s work helped the whole world.

The organization, based near the Riley Hospital for Children in Indianapolis, is affiliated with the IU Medical School. Their decade-old “LOINC” system (Logical Observation Identifiers, Names and Codes) enables researchers, hospitals, governments, insurance companies and smartphone users to exchange health data across systems. It brings together isolated health data in the same language.

In January 2020, Regenstrief worked with global partners to define codes that would enable the exchange of COVID-19 data worldwide.

“Without developing these codes,” said Dr. Peter Embí, President and CEO of Regenstrief, “we couldn’t have known so quickly what the results of the laboratory tests were, what they showed and how they flowed.”

At home, Regenstrief researchers teaching at Indiana University’s Richard M. Fairbanks School of Public Health followed the Indiana Department of Health’s call to conduct a nationwide COVID prevalence study in the early days of the pandemic.

“This nationwide prevalence study was instrumental in the decisions both the governor and local health authorities made,” said Brian Dixon, Ph.D. Dixon is both Associate Professor at the Fairbanks School of Public Health and Director of Public Health Informatics at Regenstrief.

“We didn’t understand how many people were infected at the time or how widespread the infection was across the state,” added Dixon. “That’s what this early study really gave us. It enabled us to study the spread of this disease in the population. “

Before the pandemic, Dixon was compiling numbers on obesity, diabetes, and chronic diseases. He was baffled when the COVID-19 numbers turned political.

“What surprised me the most was the people’s reaction, the rejection of the numbers and then the distrust in them,” he said. “Because we’ve worked so hard here to collect accurate data from as many places as possible, bring it all together, and create the state’s dashboard. Then a lot of people say, ‘Oh, they’re just making up numbers’ or ‘That’s not the truth’.

“Well, that’s as close to the truth as possible.”

When asked whether Regenstrief is Indiana’s secret weapon against COVID-19, Embí distracts.

“I wouldn’t say we were the only one. We contributed, but to be honest, it wouldn’t have been possible without a team effort. I think we were an important part of it. And I don’t mean to sound immodest, but I think we played a really, very important role and that has undoubtedly helped us stand out from the crowd. We are really proud to be welcomed by the Governor and Dr. Box to have been recognized for our contributions. But the truth is, in Indiana we have such an incredibly collaborative place where Hoosiers come together to help one another. This really is the secret sauce. That is really the secret weapon. “

Continue Reading
Advertisement

Trending